{
  "retracted": false,
  "timestamp": 1422748800000,
  "updates": [
    {
      "timestamp": 1496030161211,
      "identifier": {
        "doi": "10.1016/j.lungcan.2014.12.001"
      },
      "type": "err"
    }
  ],
  "identifier": {
    "doi": "10.1016/j.lungcan.2014.07.006"
  },
  "publisher": "Elsevier BV",
  "title": "Corrigendum to “Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study” [Lung Cancer 85 (2014) 415–419]"
}
